- Home
- Companies
- afghanistan
- monoclonal secondary antibody
Refine by
Monoclonal Secondary Antibody Suppliers Serving Afghanistan
78 companies found
based inNeuried, GERMANY
MIKROGEN's scope of business covers the development, production and distribution of genetically engineered in vitro diagnostics. The company focuses on the serology of bacterial, viral and parasitic infections as well as on auto immune diseases. ...
Storage and Shelf Life: At 2-8°C short term. At ≤-15°C for long term ...
based inLake Linden, MICHIGAN (USA)
NECi Superior Enzymes, previously 'The Nitrate Elimination Company, Inc.', is a woman-owned small business located in Michigan's Upper Peninsula. NECi's specialty is designing and producing recombinant proteins for inclusion in quantification test ...
based inCambridge, UNITED KINGDOM
Based in Cambridge, one of Europe's largest bioscience hubs, Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific community. We achieve this by collaborating with the world’s finest researchers and ...
Plasma cells are specialised B lymphocytes that secrete antibodies (glycoproteins) in response to infection by antigens (toxins or foreign substances). Antibodies, also known as immunoglobulins (Ig), usually have a high affinity to a specific ...
based inBerlin, GERMANY
sifin diagnostics gmbh has emerged from the former ‚Staatliches Institut für Immunpräparate und Nährmedien‘ of the GDR. Thanks to investments of a German family of entrepreneurs in 1992, the diagnostics division (microbiology and blood group ...
Intended use: Test cards for ABO identity checking before blood ...
based inLouvain-la-Neuve, BELGIUM
MORE THAN 30 YEARS OF EXPERIENCE IN IVD (KITS & INSTRUMENTATION). DIAsource ImmunoAssays® S.A. (A BioVendor Group company) is an international diagnostic company based in Belgium with more than 30 years of experience in IVD (kits and ...
Clone: OBV4, Batch": [Batch dependent], Size: [> 1 mg], Format: Purified Unconjugated, Liquid, Concentration: [> 1 mg/mL, Batch dependent], Buffer: 0.05 M phosphate buffer, 0.1 M NaCI pH 7.2, Preservative: None, Purification: Protein G ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
Advances in the field of immuno-oncology have led to new and better treatment outcomes for a range of cancers, and particularly, blood cancers. However, even with the advent of checkpoint inhibitors as immunotherapies for solid tumors, significant ...
based inMinneapolis, MINNESOTA (USA)
Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services. Science ...
based inSan Diego, CALIFORNIA (USA)
Founded originally in Vancouver, British Columbia in 2006 by three enthusiastic entrepreneurs passionate about providing the best biological reagents worldwide, MyBiosource, Inc. was incorporated as a company with big visions. Since 2007, we have ...
(Basal Cell) Cytokeratin. Host/Reactivities: Host: Mouse / Reactivity: Human, Rat, Rabbit, Chicken, Quail, Hamster, Canine, Swine. Purification: Protein A/G Chromatography. Isotype/Clone: Isotype: IgG1 / Clone RCK103. Applications: Western Blot ...
based inRochester Hills, MICHIGAN (USA)
Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery. The company’s primary focus is on the identification and assay of biomarkers for ...
based inCambridge, MASSACHUSETTS (USA)
Alnylam is the Leading RNAi Therapeutics Company. Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life ...
based inSan Diego, CALIFORNIA (USA)
Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved ...
Human Adenoviruses are a large group of DNA viruses that were first isolated from an adenoid gland in 1953.1 There are over 50 different serotypes.2 Adenovirus infections are often asymptomatic, but can cause a wide range of illnesses and symptoms ...
based inGrabels, FRANCE
Innovative Diagnostics is committed to the 'One Health' concept by offering diagnostic reagents for veterinary and zoonotic infectious diseases. Innovative Diagnostics is specialized in the development, production, and commercialization of ...
Monoclonal antibody against Bovine Herpes Virus type 4 ...
based inMilpitas, CALIFORNIA (USA)
BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other ...
Cas9 (CRISPR associated protein 9) is an RNA-guided DNA endonuclease enzyme associated with the CRISPR (Clustered Regularly Interspersed Palindromic Repeats) adaptive immunity system in Streptococcus pyogenes and other bacteria. Cas9 is used to ...
based inKävlinge, SWEDEN
The Genovis Group consists of Genovis AB, Sweden, and the wholly owned subsidiary Genovis Inc., USA. The company's shares are listed on Nasdaq First North Growth Market. Genovis’ business concept is to offer customers in the biopharmaceutical and ...
The custom antibody services include monoclonal and polyclonal antibody development, in vitro monoclonal antibody production, anti-idiotype antibody development and antibody ...
based inLimerick, PENNSYLVANIA (USA)
Rockland Immunochemicals, Inc. offers a robust catalog of antibodies to suit any project. No matter the context—basic research to disease therapy, phosphorylated to methylated, and beyond—Rockland embraces the challenge to design, produce, validate, ...
CD45 is encoded by the PTPRC (Protein tyrosine phosphatase receptor type C) gene. CD45, also known as the leukocyte common antigen (LCA), is a member of the protein tyrosine phosphatase (PTP) family. It is present on all human leukocytes including ...
based inDallas, TEXAS (USA)
Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past thirty years, Santa Cruz Biotechnology has focused on the ongoing development of research monoclonal antibodies, ...
- Anti-p53 Antibody (DO-1) is a mouse monoclonal IgG2a κ p53 antibody, cited in 6,154 publications, provided at 200 µg/ml - N-terminal epitope mapping between amino acid residues 11-25 of p53 of human origin - Anti-p53 Antibody (DO-1) is recommended ...
based inWayne, PENNSYLVANIA (USA)
Sino Biological is committed to providing high-quality recombinant protein and antibody reagents and to being a one-stop technical services shop for life science researchers around the world. All of our products are independently developed and ...
based inHellerup, DENMARK
BioPorto offers high-quality monoclonal antibodies for pharmaceutical research and IVD testing in areas such as diabetes, obesity, and allergy. BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life ...
based inFarmingdale, NEW YORK (USA)
As an epigenetics company, Epigentek Group Inc. is the leading developer and provider of innovative technologies and products for epigenetic-related research. Founded in 2005, the company has since developed a comprehensive portfolio of proprietary ...
5-hydroxymethylcytosine (5-hmC), as a sixth DNA base with functions in transcription regulation, has been detected to be abundant in human and mouse brain and embryonic stem (ES) cells. In mammals, it can be generated by oxidation of ...
based inBrea, CALIFORNIA (USA)
We are pleased to announce the exclusive commercialization and sale of KinesisDx product lines to Krishgen Biosystems, India for worldwide usage effective July 11, 2019. This is in line with our philosophy to partner with forward looking companies ...